Dr. Falk Pharma Gmbh
USPTO PatentsView assignee record - 18 granted patents across 9 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Dr. ranks #15,968 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 9 technology areas.
- #15,968
- of 49,997 US assignees by volume
- Top 40%
- by Innovation Score (38.9/100)
- 16.8
- avg claims per patent
- +25%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R15968 · Foreign Corporation #15,968 · 18 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-MICRO 18 grants
- MID-PACK #15,968/49,997
- PHOTO-FINISH Domtar Paper
- CPC-NARROW A61P · 9 areas
- INNOV-THIN 38.9/100
- CLAIMS-RICH 16.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +25% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Domtar Paper Company, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Dr.’s 38.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Dr.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Dr Falk Pharma · this assignee
Dr Falk Pharma · this assignee
39 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Dr.'s Innovation Score is 38.9/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Dr.?
Each dot is one of Dr.’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dr.’s own 16.8 claims/patent is ABOVE the 8.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Dr.'s grants concentrate
Dr. Falk Pharma Gmbh is a focused PatentsView assignee: 9 CPC subclasses with 88.9% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2016. By volume, Dr. sits between Domtar Paper Company, LLC and EBM Papst Landshut GmbH.
Dr.'s three-year grant acceleration
Dr. Falk Pharma Gmbh shows 6 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Dr's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Domtar Paper
Domtar Paper Company, LLC
18 patents
- Dong Guan Bright…
Dong Guan Bright Yinhuey Lighting Co., Ltd. China
18 patents
- Dongguan Zhengyan…
Dongguan Zhengyang Electronic Mechanical Co. Ltd.
18 patents
- Dorel Home Furnis…
Dorel Home Furnishings, Inc.
18 patents
- Dreame Innovation…
Dreame Innovation Technology (Suzhou) Co., Ltd.
18 patents
- Dupont Specialty…
DuPont Specialty Materials Korea Ltd.
18 patents
- Eagleburgmann Jap…
Eagleburgmann Japan Co., Ltd.
18 patents
- EBM Papst Landshut
EBM Papst Landshut GmbH
18 patents
- Dr Falk Pharma ◀
Dr. Falk Pharma Gmbh
18 patents
What this shows Dr. holds 18 patents at rank #15,968, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Dr
By rank, the assignees closest to #15,968 in granted patent volume.
- Domtar Paper Company, LLC #15,964 · 18 patents
- Dong Guan Bright Yinhuey Lighting Co., Ltd. China #15,965 · 18 patents
- Dongguan Zhengyang Electronic Mechanical Co. Ltd. #15,966 · 18 patents
- Dorel Home Furnishings, Inc. #15,967 · 18 patents
- Dreame Innovation Technology (Suzhou) Co., Ltd. #15,969 · 18 patents
- DuPont Specialty Materials Korea Ltd. #15,970 · 18 patents
- Eagleburgmann Japan Co., Ltd. #15,971 · 18 patents
- EBM Papst Landshut GmbH #15,972 · 18 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Dr's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Dr.'s Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 40% higher than 60% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 22.2% |
| 2016 | 1 | 5.6% |
| 2018 | 2 | 11.1% |
| 2019 | 1 | 5.6% |
| 2020 | 1 | 5.6% |
| 2021 | 3 | 16.7% |
| 2022 | 2 | 11.1% |
| 2023 | 2 | 11.1% |
| 2024 | 2 | 11.1% |
Which technologies does Dr. Falk Pharma Gmbh patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Dr. Falk Pharma Gmbh's patent record in context - here's where to go next.
- Dr. Falk Pharma Gmbh's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 88.9% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #15,968 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Dr. Falk Pharma Gmbh against Domtar Paper Company, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 38.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.